The FDA has granted breakthrough device designation to EaseVRx (AppliedVR) for the treatment of resistant fibromyalgia and chronic intractable lower back pain. The designation was based in part on a randomized controlled trial of the device evaluating the feasibility, efficacy and acceptability of virtual reality (VR)-based digital behavioral therapy for self-management of chronic pain at home.